Chapter 3.2. Anticholinergic Bronchodilators in Chronic Obstructive Pulmonary Disease Therapy

  1. Peter G. Gibson1,
  2. Michael Abramson2,
  3. Richard Wood-Baker3,
  4. Jimmy Volmink4,
  5. Michael Hensley5 and
  6. Ulrich Costabel6
  1. Alicia R ZuWallack and
  2. Richard L ZuWallack

Published Online: 25 OCT 2007

DOI: 10.1002/9780470987377.ch19

Evidence-based Respiratory Medicine

Evidence-based Respiratory Medicine

How to Cite

ZuWallack, A. R. and ZuWallack, R. L. (2005) Anticholinergic Bronchodilators in Chronic Obstructive Pulmonary Disease Therapy, in Evidence-based Respiratory Medicine (eds P. G. Gibson, M. Abramson, R. Wood-Baker, J. Volmink, M. Hensley and U. Costabel), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470987377.ch19

Editor Information

  1. 1

    John Hunter Hospital, Newcastle, New South Wales, Australia

  2. 2

    Monash University, Central & Eastern Clinical School, The Alfred, Melbourne, Victoria, Australia

  3. 3

    University of Tasmania, Hobart, Tasmania, Australia

  4. 4

    University of Cape Town, Cape Town, South Africa

  5. 5

    University of Newcastle, Newcastle, New South Wales, Australia

  6. 6

    Ruhrlandklinik, Essen, Germany

Publication History

  1. Published Online: 25 OCT 2007
  2. Published Print: 22 NOV 2005

ISBN Information

Print ISBN: 9780727916051

Online ISBN: 9780470987377

SEARCH

Keywords:

  • anticholinergic bronchodilators;
  • chronic obstructive pulmonary disease therapy;
  • exercise capacity;
  • dyspnoea;
  • exacerbations

Summary

This chapter contains sections titled:

  • Introduction

  • Pharmacology of anticholinergic bronchodilators

  • General search strategy

  • Conclusion